Menarini Stemline
Biopharmaceutical company developing cancer treatments
- B2B
About Menarini Stemline
Development and commercialization of innovative targeted therapies for cancer patients, including FDA-approved ELZONRIS and clinical-stage candidates.
Key facts
- Industry
- Biotechnology
- Company size
- 251–1,000 employees
- Headquarters
- new york, United States
- Revenue
- $49.5M – $391MTamtam estimate
- Website
- stemline.com
Menarini Stemline at a glance
Menarini Stemline is a B2B company in the Biotechnology industry, headquartered in new york, United States.
Menarini Stemline has 251–1,000 employees.
Menarini Stemline's revenue is $49.5M – $391M (Tamtam estimate).
Selling to companies like Menarini Stemline?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies